Phase 2 Open-label, Single-arm, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Camostat Mesylate in Patients with Protein-losing Enteropathy after Fontan Operation-Preliminary Outcome

被引：0
|
作者：
Park, Woo Young
Kim, Gi Beom
Lee, Sang
Baek, Jae Suk
Kim, Soo Jin
Jung, Jowon
Hyun, Myung Chul
Lim, Young Tae
Lee, Hyoung-Doo
Ko, Hoon
Lee, Joowon
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
Camostat mesylate; protein-losing enteropathy; Fontan operation;
D O I：
10.1161/circ.150.suppl_1.4144560
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4144560
引用
收藏
页数：3
相关论文
共 50 条
  • [21] An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma
    Inaki, Anri
    Shiga, Tohru
    Tsushima, Yoshito
    Jinguji, Megumi
    Wakabayashi, Hiroshi
    Kayano, Daiki
    Akatani, Norihito
    Yamase, Takafumi
    Kunita, Yuji
    Watanabe, Satoru
    Hiromasa, Tomo
    Mori, Hiroshi
    Hirata, Kenji
    Watanabe, Shiro
    Higuchi, Tetsuya
    Tomonaga, Hiroyasu
    Kinuya, Seigo
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (03) : 267 - 278
  • [22] Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma
    Kilgour, James M.
    Shah, Aatman
    Urman, Nicole M.
    Eichstadt, Shaundra
    Do, Hanh N.
    Bailey, Irene
    Mirza, Amar
    Li, Shufeng
    Oro, Anthony E.
    Aasi, Sumaira Z.
    Sarin, Kavita Y.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4717 - 4725
  • [23] Efficacy and safety of three herbal medicinal products in patients with acute bronchitis: a multi-center, randomized, open-label clinical trial
    de Zeeuw, J.
    Kehr, M. S.
    Braun, S.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S542 - S542
  • [24] Safety of Silk-elastin Sponges in Patients with Chronic Skin Ulcers: A Phase I/II, Single-center, Open-label, Single-arm Clinical Trial
    Noda, Kazuo
    Kawai, Katsuya
    Matsuura, Yoshitaka
    Ito-Ihara, Toshiko
    Amino, Yoko
    Ushimaru, Mika
    Kinoshita, Akemi
    Tada, Harue
    Abe, Hiroyasu
    Morita, Satoshi
    Shimizu, Akira
    Tsuge, Itaru
    Sakamoto, Michiharu
    Morimoto, Naoki
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2021, 9 (04) : E3556
  • [25] Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
    Yap, Timothy A.
    Nakagawa, Kazuhiko
    Fujimoto, Nobukazu
    Kuribayashi, Kozo
    Guren, Tormod Kyrre
    Calabro, Luana
    Shapira-Frommer, Ronnie
    Gao, Bo
    Kao, Steven
    Matos, Ignacio
    Planchard, David
    Chatterjee, Arkendu
    Jin, Fan
    Norwood, Kevin
    Kindler, Hedy L.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (06): : 613 - 621
  • [26] An Open-label, Single-arm, Multicenter, Phase IIa Trial to Evaluate the Safety and the Efficacy of OMT-111 in Patients with Refractory Metastatic Colorectal Cancer: Interim Results
    Jeon, Youngbae
    Ji, Eunhee
    Kim, Kyung-Ok
    Sym, Sun Jin
    Lim, Dae Ro
    Baek, Jeong-Heum
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S150 - S151
  • [27] Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups
    Zimmer, L.
    Eigentler, T.
    Vaubel, J.
    Mohr, P.
    Jradi, Z.
    Kiecker, F.
    Utikal, J.
    Simon, J. -C.
    Berking, C.
    Kaempgen, E.
    Hauschild, A.
    Dippel, E.
    Rompel, R.
    Fluck, M.
    Stadler, R.
    Herbst, R. A.
    Terheyden, P.
    Loquai, C.
    Garbe, C.
    Schadendorf, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 32 - 32
  • [28] Orismilast for mild to severe hidradenitis suppurativa: Preliminary data from osiris, a phase 2a, open-label, single-center, single-arm clinical trial
    Frederiksen, Camilla Goetzsche
    Sedeh, Farnam Barati
    Taudorf, Elisabeth
    Saunte, Ditte M. L.
    Jemec, Gregor B. E.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 134 - 135
  • [29] A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency (Jan, 10.1007/s10875-021-01181-6, 2022)
    Santamaria, Manuel
    Neth, Olaf
    Douglass, Jo A.
    Krivan, Gergely
    Kobbe, Robin
    Bernatowska, Ewa
    Grigoriadou, Sofia
    Bethune, Claire
    Chandra, Anita
    Horneff, Gerd
    Borte, Michael
    Sonnenschein, Anja
    Kralickova, Pavlina
    Ramon, Silvia Sanchez
    Langguth, Daman D.
    Gonzalez-Granado, Luis Ignacio
    Alsina, Laia
    Querolt, Montse
    Griffin, Rhonda
    Hames, Carrie
    Mondou, Elsa
    Price, Jeffrey
    Sanz, Ana
    Lin, Jiang
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (03) : 512 - 513
  • [30] Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial
    Zhao, Yi
    Zhang, Xu
    Jin, Chenxing
    Yu, Xiaomin
    Zhang, Min
    Cao, Yang
    Li, Ying
    Wang, Aman
    Shan, Xiu
    Zhang, Jia
    Wang, Juhong
    Yin, Liu
    Tan, Xiaoxin
    Liu, Jiwei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 3277 - 3285
12345